EMEA-001211-PIP01-11-M01

Key facts

Invented name
Active substance
Levofloxacin (hemihydrate)
Therapeutic area
Pneumology-allergology
Decision number
P/0187/2013
PIP number
EMEA-001211-PIP01-11-M01
Pharmaceutical form(s)
Nebuliser solution
Condition(s) / indication(s)
Treatment of cystic fibrosis
Route(s) of administration
Inhalation use
Contact for public enquiries
Aptalis Pharma SAS
Tel. +39 0521 2791
E-mail: s.donadoni@chiesi.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating